Hello and Welcome to Patientsville.com, Your Source for all DIDANOSINE information. We are dedicated to provide You with DIDANOSINE safety information. Learn about DIDANOSINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
DIDANOSINE Safety Reports
Total DIDANOSINE reports: 65.DIDANOSINE FDA safety alerts: 2001 2003 .
Reported deaths: 6 Reported hospitalizations: 9.
Take DIDANOSINE Side Effects Survey or Share Your DIDANOSINE Story. Read More Here.
Health Professional from UNITED STATES reported DIDANOSINE problem on Dec 27, 2006. Female patient, 38 years of age, was diagnosed with retroviral infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: pneumonia pneumococcal, premature labour. DIDANOSINE dosage: 400 MG, QD, ORAL. During the same period patient was treated with VIREAD, KALETRA, PRENATAL VITAMINS, FOLIC ACID. Patient was hospitalized. Patient recovered.
DIDANOSINE problem was reported by a Physician from SPAIN on Dec 29, 2006. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, rash. DIDANOSINE dosage: unknown. During the same period patient was treated with KALETRA, VIRAMUNE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported DIDANOSINE problem on Dec 27, 2006. Female patient, 31 years of age, was diagnosed with retroviral infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. DIDANOSINE dosage: unknown. During the same period patient was treated with NORVIR, FUZEON, REYATAZ, EPIVIR, VALGANCICLOVIR, COTRIMOXAZOL COPHAR. Patient died.
DIDANOSINE problem was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 56 years of age, weighting 169.0 lb, was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, pancreatitis acute. DIDANOSINE dosage: 250 MG PO QD. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Male patient, 58 years of age, weighting 123.5 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 48 years of age, weighting 132.3 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. DIDANOSINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Male patient, child 10 years of age, weighting 48.50 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 59 years of age, weighting 103.6 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, ABACAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Male patient, weighting 180.8 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 43 years of age, weighting 85.98 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Female patient, 35 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 41 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, AMPRENAVIR, LAMIVUDINE. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 41 years of age, weighting 103.6 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Male patient, 60 years of age, weighting 154.3 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR, SAQUINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 58 years of age, weighting 169.8 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR, LAMIVUDINE. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Male patient, 47 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, LOPINAVIR, LAMIVUDINE. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 49 years of age, weighting 127.9 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, TIPRANAVIR, ABACAVIR, LAMIVUDINE. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Feb 02, 2007. Female patient, 25 years of age, weighting 242.1 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: congenital teratoma. DIDANOSINE dosage: 250 MG, QD, ORAL. During the same period patient was treated with TENOFOVIR, NELFINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Feb 22, 2007. Female patient, 32 years of age, weighting 119.0 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hepatitis, pneumonia bacterial, sepsis. DIDANOSINE dosage: 250 MG QD PO. During the same period patient was treated with ATAZANAVIR SULPHATE, EMTRICITABINE, CEFTRIAXONE, GENTAMICIN, BACTRIM, FERROUS SULPHATE. Patient died on 08/23/2006.
Consumer or non-health professional from UNITED STATES reported DIDANOSINE problem on Feb 05, 2007. Male patient was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, eyelid disorder. DIDANOSINE dosage: unknown. During the same period patient was treated with EPIVIR, CRIXIVAN. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 01, 2007. Female patient, child 6 years of age, weighting 63.93 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: precocious puberty. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, NELFINAVIR, RITONAVIR, ZIDOVUDINE. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Mar 12, 2007. Female patient, 32 years of age, weighting 119.0 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hepatitis, pneumonia bacterial, sepsis. DIDANOSINE dosage: 250 MG OD PO. During the same period patient was treated with ATAZANAVIR SULPHATE, EMTRICITABINE, CEFTRIAXONE, GENTAMICIN, BACTRIM, FERROUS SULPHATE. Patient died on 08/23/2006.
DIDANOSINE problem was reported by a Health Professional from CANADA on Mar 26, 2007. Female patient, 68 years of age, was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, cd4 lymphocytes decreased, mitochondrial toxicity, nausea. DIDANOSINE dosage: unknown. During the same period patient was treated with VALGANCICLOVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Mar 19, 2007. Female patient was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: coarctation of the aorta, congenital anomaly. DIDANOSINE dosage: 400 MG/DAY, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED KINGDOM on May 23, 2007. Female patient, 31 years of age, weighting 133.4 lb, was diagnosed with retroviral infection, cytomegalovirus test, prophylaxis and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. DIDANOSINE dosage: 250 MG, QD, ORAL. During the same period patient was treated with NORVIR, FUZEON, VALGANCICLOVIR, REYATAZ, EPIVIR, COTRIM, LAMIVUDINE. Patient died.
Pharmacist from UNITED STATES reported DIDANOSINE problem on June 20, 2007. Male patient, 59 years of age, was diagnosed with hepatitis c, hiv infection, systemic antiviral treatment and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, pancreatitis. DIDANOSINE dosage: 250MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on June 14, 2007. Female patient, 37 years of age, was diagnosed with hiv infection, prophylaxis against hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, coarctation of the aorta, heat rash, live birth, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. DIDANOSINE dosage: 400 MG/DAY, UNK, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on June 14, 2007. Female patient, weighting 5.73 lb, was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus. DIDANOSINE dosage: 400 MG/DAY, TRANSPLACENTAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from FRANCE on Jan 31, 2006. Male patient, 46 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis, sepsis. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE. Patient died.
Health Professional from LUXEMBOURG reported DIDANOSINE problem on Jan 31, 2006. Male patient, 48 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis, t-cell lymphoma. DIDANOSINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient died.
DIDANOSINE problem was reported by a Health Professional from FRANCE on July 10, 2006. Male patient, 45 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, lymphoma. DIDANOSINE dosage: unknown. During the same period patient was treated with NORVIR, VIREAD, FUZEON. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on July 07, 2006. Male patient was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: trisomy 21. DIDANOSINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, NEVIRAPINE, KALETRA, ZIDOVUDINE. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from PORTUGAL on Aug 18, 2006. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, confusional state, cytolytic hepatitis, dehydration, hepatic steatosis, lactic acidosis, pancreatitis, pneumonia, renal failure. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, EFAVIRENZ. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Aug 17, 2006. Male patient was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: chordee, hypospadias. DIDANOSINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, NELFINAVIR, ZIDOVUDINE, RITONAVIR, EFAVIRENZ. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypospadias. DIDANOSINE dosage: unknown. During the same period patient was treated with NELFINAVIR, STAVUDINE. Patient recovered.
Consumer or non-health professional from CANADA reported DIDANOSINE problem on Aug 14, 2006. Female patient, 47 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, dyspnoea, hepatic failure, hepatic steatosis, lactic acidosis, pneumonia, shock. DIDANOSINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, BENZATROPINE, LOXAPINE. Patient was hospitalized. Patient died.
DIDANOSINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 17, 2006. Female patient was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: congenital musculoskeletal anomaly. DIDANOSINE dosage: 250 MG, QD, ORAL. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, ATAZANAVIR, RITONAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Aug 30, 2006. Male patient was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypospadias. DIDANOSINE dosage: unknown. During the same period patient was treated with NELFINAVIR, STAVUDINE. Patient recovered.
DIDANOSINE problem was reported by a Physician from UNITED STATES on Sept 18, 2006. Female patient, 32 years of age, weighting 119.0 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hepatitis, lactic acidosis, pancreatitis, pneumonia, sepsis. DIDANOSINE dosage: 250 MG OD. During the same period patient was treated with ATAZANAVIR, EMTRICITABINE. Patient died on 08/23/2006.
Health Professional from ITALY reported DIDANOSINE problem on Oct 18, 2006. Male patient, 57 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: bladder cancer. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
DIDANOSINE problem was reported by a Physician from UNITED KINGDOM on Feb 15, 2006. Male patient, child 12 years of age, weighting 55.12 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased, dehydration, fatigue, glycosuria, haematuria, nausea. DIDANOSINE dosage: unknown. During the same period patient was treated with VIREAD, KALETRA, INDINIVIR SULPHATE, ATAZANAVIR. Patient recovered.
Health Professional from UNITED KINGDOM reported DIDANOSINE problem on Feb 27, 2006. Male patient, child 12 years of age, weighting 77.16 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased, dehydration, fatigue, glycosuria, haematuria, nausea. DIDANOSINE dosage: unknown. During the same period patient was treated with VIREAD, ATAZANAVIR, KALETRA, INDINIVIR SULPHATE. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Oct 26, 2006. Female patient, 25 years of age, weighting 242.1 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: congenital teratoma, live birth. DIDANOSINE dosage: 250 MG, QD, ORAL. During the same period patient was treated with TENOFOVIR, NELFINAVIR. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported DIDANOSINE problem on Oct 25, 2006. Female patient was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: congenital musculoskeletal anomaly, live birth. DIDANOSINE dosage: 250 MG, QD; ORAL. During the same period patient was treated with TENOFOVIR FISOPROXIL FUMARATE, ATAZANAVIR, RITONAVIR. Patient recovered.
DIDANOSINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 16, 2006. Female patient, 31 years of age, was diagnosed with systemic antiviral treatment and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. DIDANOSINE dosage: unknown. During the same period patient was treated with NORVIR, FLUZEON, REYATAZ, EPIVIR, COTRIMOXAZOL, VALGANCIDOVIR. Patient died.
Health Professional from UNITED KINGDOM reported DIDANOSINE problem on Dec 11, 2006. Male patient, 59 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: lipodystrophy acquired, metastatic neoplasm, prostate cancer. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Dec 16, 2006. Female patient, 38 years of age, was diagnosed with retroviral infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: pneumonia pneumococcal, pregnancy, premature labour. DIDANOSINE dosage: 400 MG, QD, ORAL. During the same period patient was treated with VIREAD, KALETRA, PRENATAL VITAMINS, FOLIC ACID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DIDANOSINE problem on June 18, 2007. Male patient was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, eyelid disorder, ophthalmoplegia. DIDANOSINE dosage: unknown. During the same period patient was treated with EPIVIR, CRIXIVAN. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED KINGDOM on July 05, 2007. Female patient, weighting 6.61 lb, was diagnosed with human immunodeficiency virus transmission and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: failure to thrive, hepatosplenomegaly, hiv infection, lymphadenopathy, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE. Patient recovered.
Physician from SPAIN reported DIDANOSINE problem on Apr 02, 2004. Male patient, 31 years of age, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: cholestasis, hyperlactacidaemia, hypersensitivity, polyneuropathy. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, EFAVIRENZ, HYDROXYUREA, ABACAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 01, 2007. Male patient, child 12 years of age, weighting 92.59 lb, was diagnosed with hiv test positive and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood creatinine increased, cd4 lymphocytes decreased, renal tubular disorder, vomiting. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Aug 15, 2007. Female patient, 33 years of age, was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. DIDANOSINE dosage: unknown. Patient recovered.
DIDANOSINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Female patient, 37 years of age, was diagnosed with hiv infection, prophylaxis against hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, cardiac failure congestive, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. DIDANOSINE dosage: 400 MG/DAY, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Aug 16, 2007. Female patient, weighting 5.73 lb, was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, cardiac failure congestive, coarctation of the aorta, congenital anomaly, heart block congenital, heat rash, metabolic acidosis, patent ductus arteriosus. DIDANOSINE dosage: 400 MG/DAY, TRANSPLACETNAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, 37 years of age, was diagnosed with hiv infection, prophylaxis against hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. DIDANOSINE dosage: 400 MG/DAY, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Aug 24, 2007. Female patient, weighting 5.73 lb, was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, cardiac failure congestive, coarctation of the aorta, heat rash, metabolic acidosis, neonatal disorder, patent ductus arteriosus, ventricular septal defect. DIDANOSINE dosage: 400 MG, TRANSPLACENTAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Male patient, weighting 8.82 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypospadias, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with SUSTIVA, LAMIVUDINE, NELFINAVIR, INDINAVIR, RITONAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Sept 10, 2007. Female patient, weighting 2.20 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: joint dislocation, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE, ABACAVIR, NELFINAVIR, SAQUINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient, weighting 2.20 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: joint dislocation, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with SAQUINAVIR, NEVIRAPINE, ABACAVIR, NELFINAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Sept 10, 2007. Male patient, weighting 6.61 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypospadias, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, NELFINAVIR. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient, weighting 2.20 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: joint dislocation, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with SAQUINAVIR, NEVIRAPINE, ABACAVIR, NELFINAVIR. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported DIDANOSINE problem on Sept 12, 2007. Female patient, child 5 years of age, weighting 37.48 lb, was diagnosed with hiv test positive and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased. DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.
DIDANOSINE problem was reported by a Health Professional from UNITED STATES on Sept 13, 2007. Male patient, weighting 6.61 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: hypospadias, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with STAVUDINE, NELFINAVIR. Patient recovered.
Health Professional from UNITED STATES reported DIDANOSINE problem on Sept 10, 2007. Female patient, weighting 2.20 lb, was diagnosed with hiv infection and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: joint dislocation, pregnancy. DIDANOSINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE, ABACAVIR, NELFINAVIR, SAQUINAVIR. Patient recovered.